Special Issue "New Advances in Pharmacological Targets for Pain"
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: 31 October 2018
Prof. Dr. Jan Keppel Hesselink
Pain is the most common presenting physical symptom in medicine and accounts for a substantial burden to patients and healthcare. Current therapeutic approaches for pain, particularly chronic pain, often do not provide adequate relief and many therapeutic targets are often liable to various central side effects. As new ideas for analgesic drug design are urgently needed several potential targets for drug discovery with mechanisms, receptors, ion channels and enzymes, that are involved in the development and/or maintenance of pain have been identified and investigated in preclinical research. The range of proteins, cells and genetic changes involved in nociceptive signalling suggests targeting multiple events could help to determine the combination of drugs that yield effective analgesia for specific clinical conditions and diverse patients. Authors are invited to submit original and review articles of preclinical and clinical findings contributing to the understanding of novel drug targets and therapies for the treatment of pain to be published in this Special Issue of Pharmaceuticals.Dr. Kim Lawson
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 850 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- drug targets
- drug repurposing
- ion channels